TY - JOUR
T1 - Ferroptosis and Its Potential Role in Human Diseases
AU - Han, Chu
AU - Liu, Yuanyuan
AU - Dai, Rongji
AU - Ismail, Nafissa
AU - Su, Weijun
AU - Li, Bo
N1 - Publisher Copyright:
© Copyright © 2020 Han, Liu, Dai, Ismail, Su and Li.
PY - 2020/3/17
Y1 - 2020/3/17
N2 - Ferroptosis is a novel regulated cell death pattern discovered when studying the mechanism of erastin-killing RAS mutant tumor cells in 2012. It is an iron-dependent programmed cell death pathway mainly caused by an increased redox imbalance but with distinct biological and morphology characteristics when compared to other known cell death patterns. Ferroptosis is associated with various diseases including acute kidney injury, cancer, and cardiovascular, neurodegenerative, and hepatic diseases. Moreover, activation or inhibition of ferroptosis using a variety of ferroptosis initiators and inhibitors can modulate disease progression in animal models. In this review, we provide a comprehensive analysis of the characteristics of ferroptosis, its initiators and inhibitors, and the potential role of its main metabolic pathways in the treatment and prevention of various diseased states. We end the review with the current knowledge gaps in this area to provide direction for future research on ferroptosis.
AB - Ferroptosis is a novel regulated cell death pattern discovered when studying the mechanism of erastin-killing RAS mutant tumor cells in 2012. It is an iron-dependent programmed cell death pathway mainly caused by an increased redox imbalance but with distinct biological and morphology characteristics when compared to other known cell death patterns. Ferroptosis is associated with various diseases including acute kidney injury, cancer, and cardiovascular, neurodegenerative, and hepatic diseases. Moreover, activation or inhibition of ferroptosis using a variety of ferroptosis initiators and inhibitors can modulate disease progression in animal models. In this review, we provide a comprehensive analysis of the characteristics of ferroptosis, its initiators and inhibitors, and the potential role of its main metabolic pathways in the treatment and prevention of various diseased states. We end the review with the current knowledge gaps in this area to provide direction for future research on ferroptosis.
KW - degenerative diseases
KW - ferroptosis
KW - pharmacology design
KW - reactive oxygen species
KW - signaling pathways
UR - http://www.scopus.com/inward/record.url?scp=85082716475&partnerID=8YFLogxK
U2 - 10.3389/fphar.2020.00239
DO - 10.3389/fphar.2020.00239
M3 - Review article
AN - SCOPUS:85082716475
SN - 1663-9812
VL - 11
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 239
ER -